𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Role of PPARG gene variants in inflammatory bowel disease

✍ Scribed by Jürgen Glas; Julia Seiderer; Christian Markus; Simone Pfennig; Martin Wetzke; Ekaterini Paschos; Burkhard Göke; Thomas Ochsenkühn; Bertram Müller-Myhsok; Julia Diegelmann; Darina Roeske; Stephan Brand

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
62 KB
Volume
17
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Role of the PXR gene locus in inflammato
Role of the PXR gene locus in inflammatory bowel diseases
✍ Alfonso Martínez; Ana Márquez; JuanLuis Mendoza; Carlos Taxonera; Miguel Fernánd 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 2 views

## Background: The pregnane X receptor gene (PXR/NR1I2) has been recently associated with an increased risk for inflammatory bowel disease (IBD), although a subsequent case-control study failed to replicate the original association in an independent population. This nuclear receptor regulates gene

Role of diet in the development of infla
Role of diet in the development of inflammatory bowel disease
✍ Christine A. Chapman-Kiddell; Peter S.W. Davies; Lynda Gillen; Graham L. Radford 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 1 views

The inflammatory bowel diseases (IBDs) are a group of heterogeneous disorders characterized by acute and chronic inflammatory changes in the small or large bowel, or in both. Increasing incidence and prevalence figures for IBD both in the developed and developing world indicate that environmental fa

Role of chromoendoscopy in colon cancer
Role of chromoendoscopy in colon cancer surveillance in inflammatory bowel disease
✍ Henrik Thorlacius; Ervin Toth 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 2 views

Inflammation in the intestine is a well-known risk factor for neoplastic changes in the mucosa. In fact, it has been shown that long-standing ulcerative colitis and colonic Crohn's disease have a significantly increased risk for developing colorectal cancer, although the estimates vary widely betwee

Drug development in inflammatory bowel d
Drug development in inflammatory bowel disease: The role of the FDA
✍ Conor Lahiff; Sunanda Kane; Alan C. Moss 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB 👁 2 views

All medicinal compounds sold in the United States for inflammatory bowel disease (IBD) are regulated by the Food and Drug Administration (FDA) via a number of regulations dating back to 1906. The primary contemporary role of the FDA is in the assessment of safety and efficacy, and subsequent marketi